Plasma cell neoplasms Flashcards
Types of plasma cell neoplasms
Multiple myeloma
Waldenstrom macroglobulinemia
Monoclonal gammopathy of undetermined significance (MGUS)
Common cell synthesis feature of plasma cell neoplasms
Monoclonal Ig or Ig fragment
Excess monoclonal light chains as free light chains in plasma
Bence-Jones proteins and their test
Free light chains secreted in urine
Tested by urine immunofixation electrophoresis
CRAB symptoms of multiple myeloma
Hypercalcemia
Renal failure
Anemia
Lytic bone lesions
Plasma cell neoplasm with a higher incidence in older men and those of African descent
Multiple myeloma
Translocations/mutation associated with multiple myeloma
t(11;14) - cyclin D1;IgH
t(6;14) - cyclin D3;IgH
MYC mutations
Clinical manifestations of multiple myeloma
Pathological fracture
Chronic bone pain
Renal insufficiency/failures
Anemia
Hypercalcemia symptoms
Recurrent bacterial infections
AL type amyloidosis
Hypercalcemia symptoms
Weakness
Confusion
Lethargy
Constipation
Polyuria
Renal stones
Cause of renal failure in multiple myeloma
Deposition of immunoglobulins within glomeruli and tubular damage
Affect of myeloma derived MIP1-alpha
Upregulates RANKL to activate osteoclasts
Increased bone resorption leading to hypercalcemia and fracture
AL type amyloidosis
Abnormal processing of free light chains
Bone marrow plasma cell morphology in multiple myeloma
Round eccentrically placed nuclei with clumped chromatin
Blue cytoplasm
Perinuclear clearing - golgi
Plasma cell leukemia in multiple myeloma
Abnormal bone marrow plasma cells spill into peripheral circulation
Immunophenotype of abnormal bone marrow plasma cells in multiple myeloma
CD138/syndecan-1 positive
CD56+
Anemia
Normal or decreased WBC and platelets
Elevated ESR
Hypercalcemia
Elevated creatinine and BUN
Urinary excretion of BJP
Monoclonal M protein >3 in serum electrophoresis
Plasma cell infiltration of bone marrow
Lytic lesions
Multiple myeloma
Most common plasma cell dyscrasia
Monoclonal gammopathy of undetermined significance (MGUS)
Asymptomatic plasma cell neoplasm
MGUS
MGUS can progress to this
Multiple myeloma
Diagnostic criteria of MGUS
Serum monoclonal protein <3
Clonal plasma cells <10%
Absence of end organ damage
B cell neoplasm of older adults
Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia
Hyperviscosity syndrome mechanism and associated disease
Plasma cell component secretes monoclonal IgM
Waldenstrom macroglobulinemia
MYD88 gene mutation
Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma
Clinical features of Waldenstrom macroglobulinemia
Lymphadenopathy
Hepatomegaly
Splenomegaly
Anemia
Symptoms of hyperviscosity syndrome
Visual impairment
Neurologic problems (HA, dizziness, stupor)
Bleeding
Cryoglobulinemia
Cryoglobulinemia
Precipitation of Ig at low temps
Raynaud phenomenon
Cold urticaria
Normal Langerhans cells
Tissue resident macrophages
Form network across epidermis
Ability to migrate to draining lymph nodes
Typical age of LCH/Histiocytosis X
1-3 yo
Types of LCH
Eosinophilic granuloma
Hand-Schuller-Christian disease
Letterer-Siwe disease
Pulmonary LCH
General characteristics of eosinophilic granuloma LCH
Unifocal
Unisystem, commonly bone
Most common in older children and adults
General characteristics of Hand-Schuller-Christian disease (LCH)
Multifocal
Unisystem
Clinical triad in Hand-Schuller-Christian disease
Calvarial bone defects
Diabetes insipidus
Exophthalmos
General characteristics of Letterer-Siwe disease
Multifocal
Multisystem
Typical age of <2 yo
Signs of Letterer-Siwe disease
Erythematous, scaly lesions
Hepatosplenomegaly
Lymphadenopathy
Lytic lesions
Recurrent infections
Cause of pulmonary LCH
Smoking
Prognosis of LCH
Unifocal associated with good prognosis
Multifocal and multisystem has poorer prognosis
Lesion biopsy findings in LCH
Langerhans cells
Eosinophils
Lymphocytes
Plasma cells
Neutrophils
Electron micrograph findings in LCH
Birbeck granules
Description of Birbeck granules
Rodlike structures with periodicity and dilated terminal end (tennis racket)
Most common mutation associated with LCH
Activation mutations involving BRAF
Immunophenotype of Langerhans cells
CD1a+
Langerin/CD207+
S-100+